[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
Evidence-Based Dermatology: Research Commentary
September 2003

Elective Lymph Node Dissection for Melanoma Laid to Rest Yet Again

Author Affiliations

Michael E.BigbyMDRosamariaCoronaDSc, MDDamianoAbeniMD, MPHPaoloPasquiniMD, MPHMoysesSzkloMD, MPH, DrPHHywelWilliamsMSc, PhD, FRCP

Arch Dermatol. 2003;139(9):1203-1204. doi:10.1001/archderm.139.9.1203

Question: Does elective lymph node dissection (ELND) decrease overall mortality in patients with melanoma and no clinically detectable regional metastases?

Data Sources: MEDLINE (1966-February 2001) and EMBASE (1974-February 2001) using the recommended Cochrane Collaboration search strategy with the MeSH (medical subject headings) terms "melanoma" and "elective lymph node." Data were also gathered from selected conference proceedings, the Controlled Trials Register from the Cochrane Library (issue 4, 2000), and unpublished data from contacted authors.

First Page Preview View Large
First page PDF preview
First page PDF preview